Influenza Division, Centers for Disease Control and Prevention, United States.
Influenza Division, Centers for Disease Control and Prevention, United States.
Virology. 2023 May;582:57-61. doi: 10.1016/j.virol.2023.03.014. Epub 2023 Apr 5.
Competition assays were conducted in vitro and in vivo to examine how the Delta (B.1.617.2) variant displaced the prototype Washington/1/2020 (WA/1) strain. While WA/1 virus exhibited a moderately increased proportion compared to that in the inoculum following co-infection in human respiratory cells, Delta variant possessed a substantial in vivo fitness advantage as this virus becoming predominant in both inoculated and contact animals. This work identifies critical traits of the Delta variant that likely played a role in it becoming a dominant variant and highlights the necessities of employing multiple model systems to assess the fitness of newly emerged SARS-CoV-2 variants.
竞争分析在体外和体内进行,以研究 Delta(B.1.617.2)变体如何取代原型华盛顿/1/2020(WA/1)株。虽然在人类呼吸道细胞中共同感染后,WA/1 病毒的比例与接种物相比略有增加,但 Delta 变体在体内具有明显的适应性优势,因为这种病毒在接种和接触动物中都占主导地位。这项工作确定了 Delta 变体的关键特征,这些特征可能在其成为主要变体中发挥了作用,并强调了采用多种模型系统来评估新出现的 SARS-CoV-2 变体适应性的必要性。